Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

ClinicalTrials.gov ID: NCT04777201

Public ClinicalTrials.gov record NCT04777201. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 11:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Patients With Neovascular Age-Related Macular Degeneration (AVONELLE-X)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This main long-term extension study is designed to evaluate the long-term safety and tolerability of faricimab 6 milligrams (mg) administered by intravitreal injection at a personalized treatment interval (PTI) to participants with neovascular age-related macular degeneration (nAMD) who enrolled in and completed one of the Phase III studies: GR40306 (NCT03823287) or GR40844 (NCT03823300), also referred to as the parent studies. Eligible patients who consent to participate in this main study will be enrolled upon completion of the end-of-study visit in the parent study. Additionally, there is a substudy that is being conducted. The aim of this substudy is to evaluate the impact of intravitreal faricimab on the health of the corneal endothelial cells in the study eyes of patients with nAMD to fulfill a U.S. Food and Drug Administration (FDA) post-marketing requirement. The fellow eyes of the same enrolled participants in the substudy will serve as the controls.

Study identification

NCT ID
NCT04777201
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
1,036 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 19, 2021 (Actual)
Primary completion
Sep 3, 2024 (Actual)
Completion
Sep 3, 2024 (Actual)
Last update posted
Oct 24, 2025

2021 – 2024

United States locations

U.S. sites
85
U.S. states
29
U.S. cities
78
Facility City State ZIP Site status
Barnet Dulaney Perkins Eye Center Mesa Arizona 85206 —
Arizona Retina and Vitreous Consultants Phoenix Arizona 85016 —
Associated Retina Consultants Phoenix Arizona 85020 —
Retina Associates Southwest PC Tucson Arizona 85704 —
Retinal Diagnostic Center Campbell California 95008 —
The Retina Partners Encino California 91436 —
South Coast Retina Center Los Angeles California 90033 —
Northern California Retina Vitreous Associates Mountain View California 94040 —
Southern CA Desert Retina Cons Palm Desert California 92211 —
California Eye Specialists Medical group Inc. Pasadena California 91107 —
Retina Consultants, San Diego Poway California 92064 —
Retina Consultants of Southern California Redlands California 92373 —
University of California, Davis, Eye Center Sacramento California 95817 —
Retinal Consultants Med Group Sacramento California 95825 —
Orange County Retina Med Group Santa Ana California 92705 —
California Retina Consultants Santa Barbara California 93103 —
Retina Consultants of Southern Colorado Springs Colorado 80909 —
Colorado Retina Associates, PC Lakewood Colorado 80228 —
Retina Group of New England Waterford Connecticut 06385 —
Rand Eye Deerfield Beach Florida 33064 —
Retina Group of Florida Fort Lauderdale Florida 33308 —
Florida Eye Associates Melbourne Florida 32901 —
Retina Care Specialists Palm Beach Gardens Florida 33410 —
Retina Specialty Institute Pensacola Florida 32503 —
Fort Lauderdale Eye Institute Plantation Florida 33324 —
Retina Vitreous Assoc of FL St. Petersburg Florida 33711 —
Southern Vitreoretinal Assoc Tallahassee Florida 32308 —
Retina Associates of Florida, LLC Tampa Florida 33609 —
Southeast Retina Center Augusta Georgia 30909 —
Georgia Retina PC Marietta Georgia 30060 —
Retina Consultants of Hawaii ‘Aiea Hawaii 96701 —
Northwestern Medical Group/Northwestern University Chicago Illinois 60611 —
University Retina and Macula Associates, PC Oak Forest Illinois 60452 —
Prairie Retina Center Springfield Illinois 62704 —
Raj K. Maturi, MD PC Indianapolis Indiana 46290 —
Wolfe Eye Clinic West Des Moines Iowa 50266 —
Retina Associates Lenexa Kansas 66215 —
Maine Eye Center Portland Maine 04101 —
Retina Specialists Baltimore Maryland 21204 —
The Retina Care Center Baltimore Maryland 21209 —
Johns Hopkins Med Baltimore Maryland 21287 —
Retina Group of Washington Chevy Chase Maryland 20815 —
Tufts Medical Center Boston Massachusetts 02111 —
Ophthalmic Consultants of Boston Boston Massachusetts 02114 —
VitreoRetinal Surgery, PLLC. Edina Minnesota 55435 —
Midwest Vision Research Foundation Chesterfield Missouri 63017 —
Retina Associates of St. Louis Florissant Missouri 63031 —
Sierra Eye Associates Reno Nevada 89502 —
Mid Atlantic Retina - Wills Eye Hospital Cherry Hill New Jersey 08034 —
NJ Retina Edison New Jersey 08820 —
Retina Associates of NJ Teaneck New Jersey 07666 —
Long Is. Vitreoretinal Consult Great Neck New York 11021 —
Ophthalmic Cons of Long Island Oceanside New York 11572 —
Retina Assoc of Western NY Rochester New York 14620 —
Vitreoretinal Consultants of New York Shirley New York 11967 —
The Retina Consultants Slingerlands New York 12159 —
Retina Vit Surgeons/Central NY Syracuse New York 13224 —
Western Carolina Retinal Associate PA Asheville North Carolina 28803 —
Char Eye Ear &Throat Assoc Charlotte North Carolina 28210 —
Graystone Eye Winston-Salem North Carolina 27104 —
Cincinnati Eye Institute Blue Ash Ohio 45242-5537 —
Retina Assoc of Cleveland Inc Cleveland Ohio 44122 —
The Ohio State University Havener Eye Institute Columbus Ohio 43212 —
Midwest Retina Dublin Ohio 43016 —
Retina Northwest Portland Oregon 97221 —
Charleston Neuroscience Inst Ladson South Carolina 29456 —
Palmetto Retina Center West Columbia South Carolina 29169 —
Black Hills Eye Institute Rapid City South Dakota 57701 —
Southeastern Retina Associates Chattanooga Chattanooga Tennessee 37421 —
Charles Retina Institute Germantown Tennessee 38138 —
Tennessee Retina PC. Nashville Tennessee 37203 —
Retina Res Institute of Texas Abilene Texas 79606 —
Austin Retina Associates Austin Texas 78705 —
Austin Clinical Research LLC Austin Texas 78750 —
Texas Retina Associates Dallas Texas 75231 —
Retina Consultants of Texas Houston Texas 77030 —
Valley Retina Institute P.A. McAllen Texas 78503 —
Retina Center of Texas Southlake Texas 76092 —
Retina Consultants of Houston The Woodlands Texas 77384 —
Strategic Clinical Research Group, LLC Willow Park Texas 76087 —
Retina Associates of Utah, PLLC Salt Lake City Utah 84107 —
Rocky Mountain Retina Salt Lake City Utah 84107 —
Piedmont Eye Center Lynchburg Virginia 24502 —
Wagner Kapoor Institute Norfolk Virginia 23451 —
Pacific Northwest Retina Silverdale Washington 98383 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 166 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04777201, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 24, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04777201 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →